Biomarker testing should be done on all patients with an initial diagnosis of advanced nonsquamous non–small cell lung cancer, but the testing rates in the real world are lower than they should be, ...

What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells? Why would they do this? VIDO scientists based at the University of ...

Researchers have built a lung in a lab that more accurately emulates the human lung than traditional models, opening the door to the fast-tracking of the discovery and development of drugs and a ...

Real-world lung cancer screening populations are older and sicker than those in the National Lung Screening Trial. Older age and more comorbidities may reduce the benefits of lung cancer screening.

Identifying genetic mutations in lung cancer has allowed researchers to develop treatments that target specific biomarkers over the past 20 years, but more research is needed to further the space. The ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung ...

Each year, about 209,000 Americans are told they have lung cancer, and about 132,000 people die from the disease, according ...

LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

Safety of DOACs in Budd-Chiari syndrome: A real-world comparison from the TriNetX Global Collaborative Network. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...